Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DURECT CORPDRRX · Entity 75335 | Director | December 07, 2021 | December 09, 2021 |
| INOVIO PHARMACEUTICALS, INC.INO · Entity 6589 | Director | May 20, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DURECT CORP
Report date December 07, 2021 · Filed December 09, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 105,000 |
Reported balance
After 2021-12-07 transaction · row 1
1 source rowRow 1 · 2021-12-07 · Purchase · Acquired 20,000 · Balance 105,000 |
INOVIO PHARMACEUTICALS, INC.
Report date May 20, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.23 · Expires 2036-05-20 | Direct | 41,800 |
Reported balance
After 2026-05-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 41,800 · Balance 41,800 F1: This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F2: Options to vest 100% on May 20, 2027. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 34,200 |
Reported balance
After 2026-05-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-20 · Grant · Acquired 34,200 · Balance 34,200 F3: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027. F1: This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. |
Filing footnotes · ownership attribution and instrument terms
F1: This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy.
F2: Options to vest 100% on May 20, 2027.
F3: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 08, 2020 Filed May 8, 2020 22:23 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | Exercise / conversionRestricted Stock Unit · Derivative | 8,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-20-000029 · wf-form4_158897658060595.xml · derivative · entry 2 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,013 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 8, 2020. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 8, 2020. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 8, 2020. Read SEC document |
| May 08, 2020 Filed May 8, 2020 22:23 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | Exercise / conversionCommon Stock | 8,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-20-000029 · wf-form4_158897658060595.xml · nonDerivative · entry 1 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 8, 2020. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 18:09 UTC | DURECT CORP DRRX · Entity 75335 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 55,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001082038-19-000016 · edgardoc.xml · derivative · entry 1 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2029-06-19 F1 · derivative.exercise_date: 100% of the total shares of this Grant Dated June 19, 2019 shall vest on the day before the first year anniversary of the Grant Date. Read SEC document |
| May 11, 2019 Filed May 13, 2019 20:01 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | Exercise / conversionRestricted Stock Unit · Derivative | 8,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-19-000040 · wf-form4_155777764433717.xml · derivative · entry 2 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,170 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested with respect to 100% of the shares on May 11, 2019. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested with respect to 100% of the shares on May 11, 2019. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested with respect to 100% of the shares on May 11, 2019. Read SEC document |
| May 11, 2019 Filed May 13, 2019 20:01 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | Exercise / conversionCommon Stock | 8,170 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-19-000040 · wf-form4_155777764433717.xml · nonDerivative · entry 1 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested with respect to 100% of the shares on May 11, 2019. Read SEC document |
| May 08, 2019 Filed May 9, 2019 22:04 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | GrantRestricted Stock Unit · Derivative | 8,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-19-000033 · wf-form4_155743947951327.xml · derivative · entry 2 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,013 Underlying: Common Stock · 8,013 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 8, 2020. F1 · shares: This grant was made pursuant to the issuer's non-employee director compensation policy. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 8, 2020. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 8, 2020. Read SEC document |
| May 08, 2019 Filed May 9, 2019 22:04 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | GrantCommon Stock Options · Derivative | 12,500 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0001055726-19-000033 · wf-form4_155743947951327.xml · derivative · entry 1 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2029-05-08 F1 · shares: This grant was made pursuant to the issuer's non-employee director compensation policy. F2 · derivative.exercise_date: Options to vest with respect to 100% of the shares on May 8, 2020. Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 18:42 UTC | DURECT CORP DRRX · Entity 75335 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 55,000 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001082038-18-000007 · edgardoc.xml · derivative · entry 1 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2028-06-19 F1 · derivative.exercise_date: 100% of the total shares of this Grant Dated June 19, 2018 shall vest on the day before the first year anniversary of the Grant Date. Read SEC document |
| May 12, 2018 Filed May 14, 2018 22:05 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | Exercise / conversionRestricted Stock Unit · Derivative | 7,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-18-000029 · wf-form4_152633549158549.xml · derivative · entry 4 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,669 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 12, 2018. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 12, 2018. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 12, 2018. Read SEC document |
| May 12, 2018 Filed May 14, 2018 22:05 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | Exercise / conversionCommon Stock | 7,669 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-18-000029 · wf-form4_152633549158549.xml · nonDerivative · entry 1 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 12, 2018. Read SEC document |
| May 11, 2018 Filed May 14, 2018 22:05 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | GrantRestricted Stock Unit · Derivative | 8,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-18-000029 · wf-form4_152633549158549.xml · derivative · entry 3 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,170 Underlying: Common Stock · 8,170 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 11, 2019. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 11, 2019. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 11, 2019. Read SEC document |
| May 11, 2018 Filed May 14, 2018 22:05 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | GrantCommon Stock Options · Derivative | 12,500 | $0.00 Strike: $4.56 | $0.00 |
DisclosureSEC source: 0001055726-18-000029 · wf-form4_152633549158549.xml · derivative · entry 2 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2028-05-11 F2 · derivative.exercise_date: Options to vest 100% on May 11, 2019. Read SEC document |
| April 12, 2018 Filed Apr 13, 2018 22:20 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | Exercise / conversionCommon Stock Options · Derivative | 3,750 | $0.00 Strike: $3.56 | $0.00 |
DisclosureSEC source: 0001055726-18-000021 · wf-form4_152365800765415.xml · derivative · entry 3 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,750 shares Expires 2018-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Given effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014. F2 · shares: Given effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014. F2 · derivative.underlying_shares: Given effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014. Read SEC document |
| April 12, 2018 Filed Apr 13, 2018 22:20 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | SaleCommon Stock | 3,750 | $5.23 | $19,618.88 |
DisclosureSEC source: 0001055726-18-000021 · wf-form4_152365800765415.xml · nonDerivative · entry 2 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,798 F1 · price: This transaction was executed in multiple trades at prices ranging from $5.23 to $5.235, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| April 12, 2018 Filed Apr 13, 2018 22:20 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | Exercise / conversionCommon Stock | 3,750 | $3.56 | $13,350.00 |
DisclosureSEC source: 0001055726-18-000021 · wf-form4_152365800765415.xml · nonDerivative · entry 1 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 25, 2017 Filed Sep 26, 2017 14:54 UTC | DURECT CORP DRRX · Entity 75335 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $0.82 | $0.00 |
DisclosureSEC source: 0001082038-17-000015 · edgardoc.xml · derivative · entry 2 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2022-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 100% of the total shares of this Grant Dated June 20, 2012 shall vest on the day before the first year anniversary of the Grant Date. Read SEC document |
| September 25, 2017 Filed Sep 26, 2017 14:54 UTC | DURECT CORP DRRX · Entity 75335 | Exercise / conversionCommon Stock | 25,000 | $0.82 | $20,495.00 |
DisclosureSEC source: 0001082038-17-000015 · edgardoc.xml · nonDerivative · entry 1 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 14:12 UTC | DURECT CORP DRRX · Entity 75335 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 16,038 | $1.06 Strike: $1.40 | $17,000.28 |
DisclosureSEC source: 0001082038-17-000008 · edgardoc.xml · derivative · entry 2 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,038 Underlying: Common Stock · 16,038 shares Expires 2027-06-19 F3 · price: This Option was issued to the reporting person in lieu of a cash retainer of $17,000. F2 · derivative.exercise_date: This Grant Dated June 19, 2017 will vest as follows: one-fourth (1/4) of the total shares subject to the option shall vest quarterly over one (1) year following the Grant Date. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 14:12 UTC | DURECT CORP DRRX · Entity 75335 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 55,000 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001082038-17-000008 · edgardoc.xml · derivative · entry 1 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 55,000 shares Expires 2027-06-19 F1 · derivative.exercise_date: 100% of the total shares of this Grant Dated June 19, 2017 shall vest on the day before the first year anniversary of the Grant Date. Read SEC document |
| May 13, 2017 Filed May 15, 2017 21:21 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | Exercise / conversionRestricted Stock Unit · Derivative | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-17-000030 · wf-form4_149488329798340.xml · derivative · entry 4 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2017. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2017. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2017. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2017. Read SEC document |
| May 13, 2017 Filed May 15, 2017 21:21 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | Exercise / conversionCommon Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-17-000030 · wf-form4_149488329798340.xml · nonDerivative · entry 1 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2017. Read SEC document |
| May 12, 2017 Filed May 15, 2017 21:21 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | GrantCommon Stock Options · Derivative | 12,500 | $0.00 Strike: $7.14 | $0.00 |
DisclosureSEC source: 0001055726-17-000030 · wf-form4_149488329798340.xml · derivative · entry 3 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2027-05-12 F3 · derivative.exercise_date: Options to vest 100% on May 12, 2018. Read SEC document |
| May 12, 2017 Filed May 15, 2017 21:21 UTC | INOVIO PHARMACEUTICALS, INC. INO · Entity 6589 | GrantRestricted Stock Unit · Derivative | 7,669 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-17-000030 · wf-form4_149488329798340.xml · derivative · entry 2 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,669 Underlying: Common Stock · 7,669 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 12, 2018. F2 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 12, 2018. F2 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 12, 2018. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 12, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.